Neonatal drug withdrawal

Pediatrics

Volumn 101, Issue 6, 1998, Pages 1079-1088

  Berlin C M , Jr ^a   McCarver, D G ^a   Notterman, D A ^a   Ward, R M ^a   Weismann, D N ^a   Wilson, G S ^a   Wilson, J T ^a   Bennett, D R ^a   Hoskins, I A ^a   Kaufman, P ^a   Mithani, S ^a   Mulinare, J ^a   MacLeod, S M ^a   Troendle, G ^a   March, J ^a   Yaffe, S J ^a   Szefler, S J ^a   Cote, C J ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

CHLORPROMAZINE; CLONIDINE; DIAZEPAM; METHADONE; OPIATE; PAREGORIC; PHENOBARBITAL;

CLINICAL FEATURE; DIFFERENTIAL DIAGNOSIS; DRUG USE; DRUG WITHDRAWAL; HUMAN; NEWBORN; PRENATAL DRUG EXPOSURE; PRIORITY JOURNAL; REVIEW; WITHDRAWAL SYNDROME;

EID: 0031840226     PISSN: 00314005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (107)

1. Khalsa JH, Gfroerer J. Epidemiology and health consequences of drug abuse among pregnant women. Semin Perinatol. 1991;15:265-270
2. Dicker M, Leighton EA. Trends in diagnosed drug problems among newborns: United States, 1979-1987. Drug Alcohol Depend. 1991;28: 151-165
3. Adams EH, Gfroerer JC, Rouse BA. Epidemiology of substance abuse including alcohol and cigarette smoking. Ann NY Acad Sci. 1989;562: 14-20
4. Substance Abuse and Mental Health Services Administration, Office of Applied Studies. Preliminary Results From the 1996 National Household Survey on Drug Abuse. Washington, DC: US Dept of Health and Human Services; August 1997
5. Harper RG, Solish GI, Purow HM, Sang E, Panepinto WC. The effect of a methadone treatment program upon pregnant heroin addicts and their newborn infants. Pediatrics. 1974;54:300-305
6. Fricker HS, Segal S. Narcotic addiction, pregnancy, and the newborn. Am J Dis Child. 1978;132:360-366
7. Madden JD, Chappel JN, Zuspan F, Gumpel J, Mejia A, Davis R. Observation and treatment of neonatal narcotic withdrawal. Am J Obstet Gynecol. 1977;127:199-201
8. Ostrea EM, Chavez CJ, Strauss ME. A study of factors that influence the severity of neonatal narcotic withdrawal. J Pediatr. 1976;88:642-645
9. Giannini AJ, Baumgartel P, DiMarzio LR. Bromocriptine therapy in cocaine withdrawal. J Clin Pharmacol. 1987;27:267-270
10. Chasnoff IJ, Bussey ME, Savich R, Stack CM. Perinatal cerebral infarction and maternal cocaine use. J Pediatr. 1986;108:456-459
11. Oro AS, Dixon SD. Perinatal cocaine and methamphetamine exposure: maternal and neonatal correlates. J Pediatr. 1987;111:571-578
12. Dixon SD, Bejar R. Echoencephalographic findings in neonates associated with maternal cocaine and methamphetamine use: incidence and clinical correlates. J Pediatr. 1989;115:770-778
13. Ryan L, Ehrlich S, Finnegan L. Cocaine abuse in pregnancy: effects on the fetus and newborn. Neurotoxicol Teratol. 1987;9:295-299
14. Fulroth R, Phillips B, Durand DJ. Perinatal outcome of infants exposed to cocaine and/or heroin in utero. Am J Dis Child. 1989;143:905-910
15. Hadeed AJ, Siegel SR. Maternal cocaine use during pregnancy: effect on the newborn infant. Pediatrics. 1989;84:205-210
16. Finnegan L, Kaltenbach K, Weiner S, Haney B. Neonatal cocaine exposure: assessment of risk scale. Pediatr Res. 1990;27:10A
17. Herzlinger RA, Kandall SR, Vaughan HG. Neonatal seizures associated with narcotic withdrawal. J Pediatr. 1971;91:638-641
18. Zelson C, Rubio E, Wasserman E. Neonatal narcotic addiction: 10 year observation. Pediatrics. 1971;48:178-189
19. Kandall SR, Gartner LM. Late presentation of drug withdrawal symptoms in newborns. Am J Dis Child. 1974;127:58-61
20. Pinto F, Torrioli MG, Casella G, Tempesta E, Fundaro C. Sleep in babies born to chronically heroin addicted mothers: a follow up study. Drug Alcohol Depend. 1988;21:43-47
21. van Baar AL, Fleury P, Soepatmi S, Ultee CA, Wesselman PJ. Neonatal behavior after drug dependent pregnancy. Arch Dis Child. 1989;64: 235-240
22. Bleyer WA, Marshall RE. Barbiturate withdrawal syndrome in a passively addicted infant. JAMA. 1972;221:185-186
23. Feld LH, Negus JB, White PF. Oral midazolam preanesthetic medication in pediatric outpatients. Anesthesiology. 1990;73:831-834
24. Pierog S, Chandavasu O, Wexler I. Withdrawal symptoms in infants with the fetal alcohol syndrome. J Pediatr. 1977;90:630-633
25. Prenner BM. Neonatal withdrawal syndrome associated with hydroxyzine hydrochloride. Am J Dis Child. 1977;131:529-530
26. Steg N. Narcotic withdrawal reactions in the newborn. Am J Dis Child. 1957;94:286-288
27. Nichols MM. Acute alcohol withdrawal syndrome in a newborn. Am J Dis Child. 1967;113:714-715
28. Desmond MM, Schwanecke RP, Wilson GS, Yasunaga S, Burgdorff I. Maternal barbiturate utilization and neonatal withdrawal symptomatology. J Pediatr. 1972;80:190-197
29. Rementeria JL, Bhatt K. Withdrawal symptoms in neonates from intrauterine exposure to diazepam. J Pediatr. 1977;90:123-126
30. Athinarayanan P, Pierog SH, Nigam SK, Glass L. Chlordiazepoxide withdrawal in the neonate. Am J Obstet Gynecol. 1976;124:212-213
31. Desmond MM, Wilson GS. Neonatal abstinence syndrome: recognition and diagnosis. Addict Dis. 1975;2:113-121
32. Harper RG, Solish G, Feingold E, Gersten-Woolf NB, Sokal MM. Maternal ingested methadone, body fluid methadone, and the neonatal withdrawal syndrome. Am J Obstet Gynecol. 1977;129:417-424
33. Doberczak TM, Kandall SR, Wilets I. Neonatal opiate abstinence syndrome in term and preterm infants. J Pediatr. 1991;118:933-937
34. Doberczak TM, Kandall SR, Friedmann P. Relationships between maternal methadone dosage, maternal-neonatal methadone levels, and neonatal withdrawal. Obstet Gynecol. 1993;81:936-940
35. Rosen TS, Pippenger CE. Disposition of methadone and its relationship to severity of withdrawal in the newborn. Addict Dis. 1975;2: 169-178
36. Mack G, Thomas D, Giles W, Buchanan N. Methadone levels and neonatal withdrawal. J Paediatr Child Health. 1991;27:96-100
37. Strauss ME, Andresko M, Stryker JC, Wardell JN. Relationship of neonatal withdrawal to maternal methadone dose. Am J Drug Alcohol Abuse. 1976;3:339-345
38. Sutton LR, Hinderliter SA. Diazepam abuse in pregnant women on methadone maintenance: implications for the neonate. Clin Pediatr (Phila). 1990;29:108-111
39. Kreek MJ, Schecter A, Gutjahr CL, et al. Analyses of methadone and other drugs in maternal and neonatal body fluids: use in evaluation of symptoms in a neonate of mother maintained on methadone. Am J Drug Alcohol Abuse. 1974;1:409-419
40. Misra AL, Pontani RB, Vadlamani NL. Stereospecific potentiation of opiate analgesia by cocaine: predominant role of noradrenaline. Pain. 1987;28:129-138
41. Misra AL, Pontani RB, Vadlamani NL. Blockade of tolerance to morphine analgesia by cocaine. Pain. 1989;38:77-84
42. Kosten TA. Cocaine attenuates the severity of naloxone-precipitated opioid withdrawal. Life Sci. 1990;47:1617-1623
43. Kosten TA, Jacobsen LK, Kosten TR. Severity of precipitated opiate withdrawal predicts drug dependence by DSM-III-R criteria. Am J Drug Alcohol Abuse. 1989;15:237-250
44. Aghajanian GK. Tolerance of locus coeruleus neurones to morphine and suppression of withdrawal response by clonidine. Nature. 1978; 276:186-188
45. Chasnoff IJ, Burns WJ, Schnoll SH, Burns KA. Cocaine use in pregnancy. N Engl J Med. 1985;313:666-669
46. Frank DA, Zuckerman BS, Amaro H, et al. Cocaine use during pregnancy: prevalence and correlates. Pediatrics. 1988;82:888-895
47. Ostrea EM, Brady MJ, Parks PM, Asenio DC, Naluz A. Drug screening of meconium in infants of drug-dependent mothers: an alternative to urine testing. J Pediatr. 1989;115:474-477
48. Ryan RM, Wagner CL, Schultz JM, et al. Meconium analysis for improved identification of infants exposed to cocaine in utero. J Pediatr. 1994;125:435-440
49. Chasnoff IJ, Burns KA, Burns WJ. Cocaine use in pregnancy: perinatal morbidity and mortality. Neurotoxicol Teratol. 1987;9:291-293
50. Mitchell M, Sabbagha RE, Keith L, MacGregor S, Mota JM, Minoque J. Ultrasonic growth parameters in fetuses of mothers with primary addiction to cocaine. Am J Obstet Gynecol. 1988;159:1104-1109
51. Cregler LL, Mark H. Medical complications of cocaine abuse. N Engl J Med. 1986;315:1495-1500
52. Chasnoff IJ, Griffith DR, MacGregor S, Dirkes K, Burns KA. Temporal patterns of cocaine use in pregnancy: perinatal outcome. JAMA. 1989; 261:1741-1744
53. American College of Obstetrics and Gynecology Committee Opinion. Committee on Obstetrics: Maternal and Fetal Medicine. Cocaine Abuse: Implications for Pregnancy. Washington, DC: American College of Obstetrics and Gynecology; 1990;81
54. Strauss ME, Starr RH, Ostrea EM, Chavez CJ, Stryker JC. Behavioral concomitants of prenatal addiction to narcotics. J Pediatr. 1976;89: 842-846
55. Chavez GF, Mulinare J, Cordero JF. Maternal cocaine use during early pregnancy as a risk factor for congenital urogenital anomalies. JAMA. 1989;262:795-798
56. Bulbul ZR, Rosenthal DN, Kleiniman CS. Myocardial infarction in the perinatal period secondary to maternal cocaine abuse: a case report and literature review. Arch Pediatr Adolesc Med. 1994;148:1092-1096
57. Horowitz RM. Drug use in pregnancy: to test, to tell: legal implications for the physician. Semin Perinatol. 1991;15:324-330
58. Lipsitz PJ. A proposed narcotic withdrawal score for use with newborn infants, a pragmatic evaluation of its efficacy. Clin Pediatr. 1975;14: 592-594
59. Finnegan LP, Kron RE, Connaughton JF, Emich JP. Assessment and treatment of abstinence in the infant of the drug-dependent mother, Int J Clin Pharmacol Biopharm. 1975;12:19-32
60. Hill RM, Desmond MM. Management of the narcotic withdrawal syndrome in the neonate. Pediatr Clin North Am. 1963;10:67-86
61. Wilson GS. Somatic growth effects of perinatal addiction. Addict Dis. 1975;2:333-345
62. Bays J. The care of alcohol-and drug-affected infants. Pediatr Ann. 1992;21:485-495
63. Finnegan LP. Neonatal abstinence. In: Nelson NM, ed. Current Therapy in Neonatal-Perinatal Medicine. Toronto, Ontario: BC Decker, Inc; 1985: 262-270
64. Ostrea EM. Infants of drug-dependent mothers. In: Burg FD, Ingelfinger JR, Wald ER, eds. Current Pediatric Therapy. Vol 14. Philadelphia, PA: WB Saunders; 1993:800-801
65. Kahn EJ, Neumann LL, Polk GA. The course of the heroin withdrawal syndrome in newborn infants treated with phenobarbital or chlorpromazine. J Pediatr. 1969;75:495-500
66. Chasnoff IJ, Burns WJ. The Moro reaction: a scoring system for neonatal narcotic withdrawal. Dev Med Child Neural. 1984;26:484-489
67. Green M, Suffet F. The neonatal narcotic withdrawal index: a device for the improvement of care in the abstinence syndrome. Am J Drug Alcohol Abuse. 1981;8:203-213
68. Kaltenbach K, Finnegan LP. Neonatal abstinence syndrome, pharmacotherapy and developmental outcome. Neurobehav Toxicol Teratol. 1986;8:353-355
69. Pacifico P, Nardelli E, Pantarotto MF. Neonatal heroin withdrawal syndrome: evaluation of different pharmacological treatments. Pharmacol Res. 1989;21:63-64
70. Carin I, Glass L, Parekh A, Solomon N, Steigman J, Wong S. Neonatal methadone withdrawal: effect of two treatment regimens. Am J Dis Child. 1983;137:1166-1169
71. Kandall SR, Doberczak TM, Mauer KR, Strashum RH, Korts DC. Opiate vs CNS depressant therapy in neonatal drug abstinence syndrome. Am J Dis Child. 1983;137:378-382
72. Kron RE, Litt M, Eng D, Phoeniz MD, Finnegan LP. Neonatal narcotic abstinence: effects of pharmacotherapeutic agents and maternal drug usage on nutritive sucking behavior. J Pediatr. 1976;88:637-641
73. Gershanik J, Boecler B, Ensley H, McCloskey S, George W. The gasping syndrome and benzyl alcohol poisoning. N Engl J Med. 1982;307: 1384-1388
74. Brown WJ, Buist NR, Gipson HT, Huston RK, Kennaway NG. Fatal benzyl alcohol poisoning in a neonatal intensive care unit. Lancet. 1982;1:1250
75. American Academy of Pediatrics, Committee on Fetus and Newborn and Committee on Drugs. Benzyl alcohol: toxic agent in neonatal units. Pediatrics. 1983;72:356-358
76. Rice TB. Paregoric intoxication with pulmonary edema in infancy. Clin Pediatr. 1984;23:101-103
77. Wijburg FA, de Kleine MJ, Fleury P, Soepatmi S. Morphine as an anti-epileptic drug in neonatal abstinence syndrome. Acta Paediatr Scand. 1991;80:875-877
78. Twarog FJ, Leung DY. Anaphylaxis to a component of isoetharine (sodium bisulfite). JAMA. 1982;248:2030-2031
79. Wysowski DK, Flynt JW, Goldfield M, Altman R, Davis AT. Epidemic neonatal hyperbilirubinemia and use of a phenolic disinfectant detergent. Pediatrics. 1978;61:165-170
80. Mitchell AA, Louik C, Lacouture P, Slone D, Goldman P, Shapiro S. Risks to children from computed tomographic scan premedication. JAMA. 1982;247:2385-2388
81. Tobias JD, Schleien CL, Haun SE. Methadone as treatment for iatrogenic narcotic dependency in pediatric intensive care unit patients. Crit Care Med. 1990;18:1292-1293
82. Anand KJ, Arnold JH. Opioid tolerance and dependence in infants and children. Crit Care Med. 1994;22:334-342
83. Hoder EL, Leckman JF, Poulsen J, et al. Clonidine treatment of neonatal narcotic abstinence syndrome. Psychiatr Res. 1984;13:243-251
84. Baumgartner GR, Rowen RC. Transdermal clonidine versus chlordiazepoxide in alcohol withdrawal: a randomized, controlled clinical trial. South Med J. 1991;84:312-321
85. Nielsen HC, Wiriyathian S, Rosenfeld R, Leveno K, Garriott JC. Chlorpromazine excretion by the neonate following chronic in utero exposure. Pediatr Pharmacol. 1983;3:1-5
86. Cobrinik RW, Hood TR, Chusid E. The effect of maternal narcotic addiction on the newborn infant: review of the literature and report of 22 cases. Pediatrics. 1959;24:288-304
87. Finnegan LP, Mitros TF, Hopkins LE. Management of neonatal narcotic abstinence utilizing a phenobarbital loading dose method. NIDA Res Monogr. 1979;27:247-253
88. Nathenson G, Golden GS, Litt IF. Diazepam in the management of the neonatal narcotic withdrawal syndrome. Pediatrics. 1971;48:523-527
89. Schiff D, Chan G, Stern L, et al. Diazepam (Valium) for neonatal narcotic withdrawal: a question of safety. Pediatrics. 1972;49:928-930
90. Rosen M. Use of diazepam in neonatal narcotic withdrawal syndrome. Pediatrics. 1972;49:314
91. Morselli PL, Principi N, Tognoni G, et al. Diazepam elimination in premature and full term infants and children. J Perinat Med. 1973;1: 133-141
92. Schiff D, Chan G, Stern L. Fixed drug combinations and the displacement of bilirubin from albumin. Pediatrics. 1971;48:139-141
93. Chasnoff IJ, Burns WJ, Hatcher RP, Burns KA. Phencyclidine: effects on the fetus and neonate. Dev Pharmacol Ther. 1983;6:404-408
94. Wachsman L, Schuetz S, Chan LS, Wingert WA. What happens to babies exposed to phencyclidine (PCP) in utero? Am J Drug Alcohol Abuse. 1989;15:31-39
95. Gibbs J, Newson T, Williams J, Davidson DC. Naloxone hazard in infant of opioid abuser. Lancet. 1989;2:159-160
96. Bloom RS, Cropley C. Textbook of Neonatal Resuscitation. Elk Grove Village, IL: American Heart Association/American Academy of Pediatrics; 1990:6-28-6-29
97. Kanof PD, Handelsman L, Aronson MJ, Ness R, Cochrane KJ, Rubinstein KJ. Clinical characteristics of naloxone-precipitated withdrawal in human opioid-dependent subjects. J Pharmacol Exp Ther. 1992;260: 355-363
98. Maas U, Kattner E, Weingart-Jesse B, Schafer A, Obladen M. Infrequent neonatal opiate withdrawal following maternal methadone detoxification during pregnancy. J Perinat Med. 1990;18:111-118
99. Doberczak TM, Shanzer S, Cutler R, Senie RT, Loucopoulos JA, Kandall SR. One-year follow-up of infants with abstinence-associated seizures. Arch Neurol. 1988;45:649-653
100. Slotkin TA, Whirmore WL, Salvaggio M, Seidler FJ. Perinatal methadone addiction affects brain synaptic development of biogenic amine systems in the rat. Life Sci. 1979;24:1223-1229
101. McGinty JF, Ford DH. Effects of prenatal methadone on rat brain catecholamines. Dev Neurosci. 1980;3:224-234
102. McGowan JD, Airman RE, Kanto WP. Neonatal withdrawal symptoms after chronic maternal ingestion of caffeine. South Med J. 1988;81: 1092-1094
103. Musa AB, Smith CS. Neonatal effects of maternal clomipramine therapy. Arch Dis Child. 1979;54:405
104. Casamassino PS. Thanks, but no thanks. Pediatr Dent. 1993;15:4-5
105. Rumack BH, Walravens PA. Neonatal withdrawal following maternal ingestion of ethchlorvynol (Placidyl). Pediatrics. 1973;52:714-716
106. Reveri M, Pyati SP, Pildes RS. Neonatal withdrawal symptoms associated with glutethimide (Doriden) addiction in the mother during pregnancy. Clin Pediatr. 1977;16:424-425
107. Desmond MM, Rudolph AJ, Hill RM, Claghorn JL, Dreesen PR, Burgdorff I. Behavioral alterations in infants born to mothers on psychoactive medication during pregnancy. In: Farrell G, ed. Congenital Mental Retardation. Austin, TX: University of Texas Press; 1969:235-244